Commodities Economy Shares Technology

Regeneron Sees Uptick in COVID-19 Therapy Sales As Cases Rise

Regeneron Pharmaceuticals Inc., the company responsible for developing the COVID-19 therapy drug REGEN-COV, exceeded estimates for second-quarter profits and revenue as the COVID-19 Delta variant continues to spread. In 2020, the U.S. government signed multimillion supply deals for the drug, which uses antibodies to decrease the viral load of a patient infected with